F/m Investments Life Sciences ETF (LFSC)

Overview

LFSC, standing for Life Sciences Focused Capital, operates as an investment fund dedicated to the life sciences sector. It aims to drive value and long-term growth by investing in innovative companies poised for significant advancements and market disruption, particularly those involving technological innovation, artificial intelligence, and market disruption. With a focus on US equity securities, LFSC employs an actively managed investment strategy, leveraging the depth of experience and specialized knowledge of its team. The fund's approach is methodical, incorporating an extensive 10-step research process to ensure thorough analysis and selection of companies with high growth potential. This process includes the review of both publicly available and third-party information, detailed financial and valuation modeling, and direct engagement with management teams, industry experts, and medical professionals.

Products and Services

LFSC's products and services are characterized by a diverse investment portfolio within the life sciences sector, covering:

• Biotechnology

  This includes investment in companies engaged in the research and development of transformative biological-based therapies, drug discovery processes, and genetic research. The focus is on entities that develop innovative healthcare solutions with the potential to disrupt the market and improve patient outcomes.

• Pharmaceuticals

  LFSC invests in pharmaceutical companies at the forefront of developing novel drugs and treatments. These investments target firms that show promise in creating breakthrough medications with substantial market potential, factoring in advancements in drug delivery systems and pharmacodynamics.

• Medical Diagnostics and Devices

  The fund shows a keen interest in companies innovating in diagnostics and medical devices, including those introducing new diagnostic techniques, medical instruments, and devices that enhance patient care, improve diagnosis accuracy, and the overall efficiency of healthcare services.

• Healthcare Services and Technologies

  Investments extend to entities offering revolutionary healthcare services and technologies that streamline operations, patient care, and healthcare management systems. These include digital health platforms, telemedicine services, and IT solutions that facilitate better healthcare delivery.

• Synthetic Biology

  LFSC seeks opportunities in synthetic biology, a field combining biology and engineering for the design and construction of new biological parts, devices, and systems. Investments are directed towards companies that leverage these capabilities to create sustainable solutions in healthcare, agriculture, and biomaterials.

In addition to these core areas, LFSC allocates up to 20% of its investment toward foreign companies listed on a US exchange, aiming to diversify its portfolio and tap into the growth potential of life sciences firms worldwide.